Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
BTIG healthcare/med devices analysts to hold an analyst/industry conference call » 13:25
03/19/20
03/19
13:25
03/19/20
13:25
XENT

Intersect ENT

$11.20 /

+2.18 (+24.17%)

Medical Devices Analysts,…

Medical Devices Analysts, along with Dr. Jonathan Overdevest, discuss the current trends for in-office intra-nasal corticosteroids and provide feedback on Intersect ENT (XENT) SINUVA on an Analyst/Industry conference call to be held on March 19 at 2 pm.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
BTIG healthcare/med devices analysts to hold an analyst/industry conference call » 04:55
03/19/20
03/19
04:55
03/19/20
04:55
XENT

Intersect ENT

$9.02 /

-0.4 (-4.25%)

Medical Devices Analysts,…

Medical Devices Analysts, along with Dr. Jonathan Overdevest, discuss the current trends for in-office intra-nasal corticosteroids and provide feedback on Intersect ENT (XENT) SINUVA on an Analyst/Industry conference call to be held on March 19 at 2 pm.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Intersect ENT trading resumes  09:40
03/18/20
03/18
09:40
03/18/20
09:40
XENT

Intersect ENT

$9.42 /

+ (+0.00%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Intersect ENT trading halted, volatility trading pause  09:35
03/18/20
03/18
09:35
03/18/20
09:35
XENT

Intersect ENT

$9.42 /

+0.21 (+2.28%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Intersect ENT trading resumes  10:00
03/17/20
03/17
10:00
03/17/20
10:00
XENT

Intersect ENT

$8.83 /

-0.38 (-4.13%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Intersect ENT trading halted, volatility trading pause  09:50
03/17/20
03/17
09:50
03/17/20
09:50
XENT

Intersect ENT

$9.99 /

+0.78 (+8.47%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Intersect ENT trading halted, volatility trading pause  15:57
03/16/20
03/16
15:57
03/16/20
15:57
XENT

Intersect ENT

$10.67 /

-5.135 (-32.50%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
BTIG healthcare/med devices analysts to hold an analyst/industry conference call » 14:32
03/11/20
03/11
14:32
03/11/20
14:32
XENT

Intersect ENT

$21.79 /

-1.92 (-8.10%)

Medical Devices Analysts,…

Medical Devices Analysts, along with Dr. Jonathan Overdevest, discuss the current trends for in-office intra-nasal corticosteroids and provide feedback on Intersect ENT (XENT) SINUVA on an Analyst/Industry conference call to be held on March 19 at 2 pm.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
Recommendations
CMS update didn't include J-code price for Intersect ENT, says SVB Leerink » 11:45
03/03/20
03/03
11:45
03/03/20
11:45
XENT

Intersect ENT

$22.44 /

-0.3 (-1.32%)

SVB Leerink analyst…

SVB Leerink analyst Richard Newitter noted that the ASP pricing file released by the CMS on March 2 did not include a reference ASP for the J-code J7401 for Intersect ENT's Sinuva/Propel, which he said means the next opportunity will be to get a price established in June for use beginning July 1. The analyst, who noted that this is the third cycle since the J-code was established in which a reference price was submitted but not issued, told investors that the news is "not be-all-end-all" but that it would have helped. Newitter has a Market Perform rating on Intersect ENT shares.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Intersect ENT backs FY20 revenue guidance of $115M-$119M, consensus $119.41M  07:11
02/24/20
02/24
07:11
02/24/20
07:11
XENT

Intersect ENT

$26.77 /

-0.79 (-2.87%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.